Search

everythinglearnresearchcommunity

for

Search:↓

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.

New treatments for hair loss show promise with advanced therapies and better targeting.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Female hair loss linked to metabolic syndrome, not in males.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Understanding sex and gender differences can improve personalized dermatology care.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.